Nifty
Sensex
:
:
15945.45
53240.27
-294.85 (-1.82%)
-968.26 (-1.79%)

Pharmaceuticals & Drugs

Rating :
45/99

BSE: 526953 | NSE: VENUSREM

252.60
18-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  259.00
  •  262.00
  •  242.80
  •  255.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  77156
  •  195.17
  •  639.00
  •  202.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 338.05
  • 4.45
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 360.39
  • N/A
  • 0.76

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 40.81%
  • 2.07%
  • 51.72%
  • FII
  • DII
  • Others
  • 0.33%
  • 0.00%
  • 5.07%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.95
  • 6.50
  • 19.41

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.28
  • 1.17
  • 10.58

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.75
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.40
  • 4.79
  • 4.51

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.43
  • 0.46
  • 0.63

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.66
  • 7.73
  • 8.27

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Net Sales
124.34
121.94
1.97%
202.56
126.07
60.67%
129.81
188.75
-31.23%
111.37
83.06
34.08%
Expenses
111.91
103.86
7.75%
175.26
115.42
51.85%
112.98
168.19
-32.83%
106.88
75.53
41.51%
EBITDA
12.44
18.08
-31.19%
27.30
10.65
156.34%
16.83
20.55
-18.10%
4.50
7.53
-40.24%
EBIDTM
10.00%
14.83%
13.48%
8.45%
12.96%
10.89%
4.04%
9.07%
Other Income
1.22
1.83
-33.33%
2.89
12.28
-76.47%
1.95
2.04
-4.41%
3.49
1.37
154.74%
Interest
0.31
1.81
-82.87%
0.03
7.39
-99.59%
0.14
2.85
-95.09%
0.96
-1.82
-
Depreciation
8.64
8.70
-0.69%
8.71
8.61
1.16%
8.62
8.59
0.35%
9.38
6.47
44.98%
PBT
4.70
13.86
-66.09%
21.46
14.52
47.80%
10.02
1.97
408.63%
18.20
-4.56
-
Tax
-0.95
2.21
-
-1.69
1.49
-
-1.68
0.00
-
-16.91
0.82
-
PAT
5.65
11.65
-51.50%
23.15
13.03
77.67%
11.70
1.97
493.91%
35.11
-5.38
-
PATM
4.54%
9.56%
11.43%
10.33%
9.01%
1.05%
31.53%
-6.48%
EPS
4.22
9.44
-55.30%
17.32
10.55
64.17%
8.75
1.60
446.88%
28.45
-4.36
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
568.08
548.12
339.33
321.89
372.41
400.04
418.27
463.99
541.56
468.64
409.84
Net Sales Growth
9.28%
61.53%
5.42%
-13.57%
-6.91%
-4.36%
-9.85%
-14.32%
15.56%
14.35%
 
Cost Of Goods Sold
365.28
340.79
174.31
181.95
205.08
227.07
238.51
268.94
300.00
262.26
225.91
Gross Profit
202.80
207.33
165.02
139.94
167.33
172.97
179.77
195.05
241.55
206.38
183.92
GP Margin
35.70%
37.83%
48.63%
43.47%
44.93%
43.24%
42.98%
42.04%
44.60%
44.04%
44.88%
Total Expenditure
507.03
494.35
298.52
289.37
332.94
349.32
337.11
374.81
403.33
348.53
306.96
Power & Fuel Cost
-
4.58
4.73
4.86
4.29
4.14
4.01
3.80
3.38
3.05
2.71
% Of Sales
-
0.84%
1.39%
1.51%
1.15%
1.03%
0.96%
0.82%
0.62%
0.65%
0.66%
Employee Cost
-
46.02
46.02
42.10
39.31
34.27
32.44
32.36
30.45
27.30
24.83
% Of Sales
-
8.40%
13.56%
13.08%
10.56%
8.57%
7.76%
6.97%
5.62%
5.83%
6.06%
Manufacturing Exp.
-
22.86
20.84
21.01
36.10
42.48
15.70
17.29
22.10
20.61
18.18
% Of Sales
-
4.17%
6.14%
6.53%
9.69%
10.62%
3.75%
3.73%
4.08%
4.40%
4.44%
General & Admin Exp.
-
16.45
17.57
11.85
13.52
13.26
11.97
15.67
14.74
11.82
12.14
% Of Sales
-
3.00%
5.18%
3.68%
3.63%
3.31%
2.86%
3.38%
2.72%
2.52%
2.96%
Selling & Distn. Exp.
-
63.64
35.05
27.60
34.65
28.10
34.48
36.75
32.65
23.50
22.98
% Of Sales
-
11.61%
10.33%
8.57%
9.30%
7.02%
8.24%
7.92%
6.03%
5.01%
5.61%
Miscellaneous Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
22.98
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.05%
EBITDA
61.07
53.77
40.81
32.52
39.47
50.72
81.16
89.18
138.23
120.11
102.88
EBITDA Margin
10.75%
9.81%
12.03%
10.10%
10.60%
12.68%
19.40%
19.22%
25.52%
25.63%
25.10%
Other Income
9.55
19.63
5.31
6.09
2.39
4.28
2.01
0.68
0.47
0.44
0.49
Interest
1.44
13.02
13.34
25.41
35.56
36.38
37.98
41.21
29.40
24.63
27.49
Depreciation
35.35
35.28
32.01
33.98
33.83
40.26
41.68
46.00
40.22
33.08
25.02
PBT
54.38
25.11
0.78
-20.77
-27.53
-21.64
3.51
2.65
69.08
62.84
50.85
Tax
-21.23
-13.21
1.96
-1.15
3.16
-4.56
1.81
-2.51
4.78
5.53
3.78
Tax Rate
-39.04%
-27.21%
-24.41%
3.87%
-11.48%
21.07%
51.57%
-94.72%
6.92%
8.80%
7.43%
PAT
75.61
61.77
-10.00
-28.57
-30.69
-17.08
1.70
5.16
64.30
57.31
47.08
PAT before Minority Interest
75.61
61.77
-10.00
-28.57
-30.69
-17.08
1.70
5.16
64.30
57.31
47.08
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
13.31%
11.27%
-2.95%
-8.88%
-8.24%
-4.27%
0.41%
1.11%
11.87%
12.23%
11.49%
PAT Growth
255.48%
-
-
-
-
-
-67.05%
-91.98%
12.20%
21.73%
 
EPS
56.43
46.10
-7.46
-21.32
-22.90
-12.75
1.27
3.85
47.99
42.77
35.13

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
400.28
323.37
332.52
361.91
388.67
437.62
456.68
461.61
379.13
307.29
Share Capital
12.34
12.34
12.34
12.34
12.34
11.44
11.44
11.44
10.54
9.74
Total Reserves
374.19
311.03
320.18
349.57
376.33
426.18
445.24
450.17
363.81
288.53
Non-Current Liabilities
58.12
95.82
136.68
158.47
179.52
212.05
221.55
161.75
147.18
113.51
Secured Loans
0.09
24.19
61.29
86.60
112.69
134.57
150.95
114.76
103.89
75.45
Unsecured Loans
46.74
47.87
54.73
50.84
49.13
56.47
51.34
25.22
25.22
23.68
Long Term Provisions
7.38
6.63
5.32
4.50
4.29
3.79
3.78
3.31
2.91
2.50
Current Liabilities
97.45
224.58
263.62
230.38
196.81
193.14
162.83
210.99
191.25
153.22
Trade Payables
71.36
36.70
36.00
29.33
29.73
25.14
29.56
31.22
18.76
12.55
Other Current Liabilities
21.10
101.70
110.30
78.47
46.16
42.71
15.96
54.70
58.18
43.44
Short Term Borrowings
4.30
85.58
112.80
121.26
119.16
123.32
115.40
110.08
95.68
83.24
Short Term Provisions
0.68
0.61
4.52
1.32
1.76
1.97
1.91
14.99
18.63
13.99
Total Liabilities
555.85
643.77
732.82
750.76
765.00
842.81
841.06
834.35
717.56
574.02
Net Block
261.68
289.37
364.45
389.20
406.18
452.48
443.65
439.46
401.42
355.39
Gross Block
616.32
623.96
707.02
702.77
686.50
679.57
641.12
587.38
511.00
430.25
Accumulated Depreciation
354.63
334.59
342.57
313.57
280.32
227.09
197.47
147.93
109.58
74.87
Non Current Assets
324.26
349.77
467.39
490.50
505.60
565.75
607.85
562.24
491.97
404.40
Capital Work in Progress
25.11
24.63
64.76
64.76
66.25
80.37
78.30
67.80
47.81
23.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
37.47
35.77
38.18
36.53
33.17
32.90
85.91
54.98
42.74
26.01
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
231.60
294.00
265.43
260.27
259.41
277.07
233.21
272.11
225.58
169.63
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
119.99
141.12
142.73
138.17
140.60
143.29
142.87
142.26
128.03
96.82
Sundry Debtors
32.04
30.69
38.04
47.27
47.29
61.59
63.22
64.99
47.11
40.10
Cash & Bank
28.98
2.13
2.81
3.98
3.56
7.07
3.62
4.41
6.36
2.95
Other Current Assets
50.58
55.72
5.15
4.84
67.96
65.12
23.51
60.47
44.08
29.77
Short Term Loans & Adv.
44.88
64.34
76.70
66.00
67.96
65.12
23.51
60.47
44.08
29.77
Net Current Assets
134.15
69.43
1.81
29.88
62.59
83.93
70.38
61.12
34.33
16.41
Total Assets
555.86
643.77
732.82
750.77
765.01
842.82
841.06
834.35
717.55
574.03

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
132.61
77.60
45.33
31.19
58.93
46.88
67.80
52.65
52.15
41.67
PBT
25.11
0.78
-20.77
-27.53
-21.64
3.51
2.65
69.08
62.84
50.85
Adjustment
23.39
41.56
60.72
66.24
70.61
56.41
83.56
37.21
40.72
29.96
Changes in Working Capital
60.67
20.82
5.37
-7.52
9.96
-13.04
-18.40
-53.65
-51.41
-39.14
Cash after chg. in Working capital
109.17
63.16
45.33
31.19
58.93
46.88
67.80
52.65
52.15
41.67
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
23.44
14.44
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
55.72
-4.75
-11.33
-11.48
-18.32
2.92
-67.18
-94.66
-103.89
-95.15
Net Fixed Assets
7.56
124.42
-5.05
-11.74
18.95
-50.18
-67.39
-93.77
-101.63
-93.38
Net Investments
0.00
0.00
0.00
28.60
0.00
0.00
0.00
0.00
0.00
-0.37
Others
48.16
-129.17
-6.28
-28.34
-37.27
53.10
0.21
-0.89
-2.26
-1.40
Cash from Financing Activity
-162.24
-73.00
-35.17
-39.23
-44.13
-46.35
-1.42
40.06
55.15
53.31
Net Cash Inflow / Outflow
26.09
-0.15
-1.17
-19.52
-3.51
3.46
-0.79
-1.95
3.41
-0.17
Opening Cash & Equivalents
1.94
2.03
3.98
0.00
7.07
3.62
4.41
6.36
2.95
3.12
Closing Cash & Equivalent
28.88
1.94
2.81
-19.52
3.56
7.07
3.62
4.41
6.36
2.95

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
313.18
262.01
269.42
293.23
314.92
382.47
399.13
403.43
355.10
306.18
ROA
10.30%
-1.45%
-3.85%
-4.05%
-2.12%
0.20%
0.62%
8.29%
8.87%
9.10%
ROE
17.40%
-3.05%
-8.23%
-8.18%
-4.13%
0.38%
1.12%
15.38%
17.04%
17.73%
ROCE
12.37%
0.90%
-0.67%
1.17%
2.00%
5.35%
5.74%
14.06%
14.85%
16.47%
Fixed Asset Turnover
0.88
0.51
0.46
0.54
0.59
0.63
0.76
0.99
1.00
1.06
Receivable days
20.89
36.97
48.37
46.34
49.67
54.45
50.42
37.72
33.88
33.71
Inventory Days
86.94
152.66
159.26
136.61
129.51
124.86
112.15
90.94
87.34
76.56
Payable days
57.86
42.82
37.91
30.30
26.74
26.74
27.25
21.28
15.09
11.03
Cash Conversion Cycle
49.96
146.80
169.72
152.65
152.44
152.57
135.32
107.37
106.14
99.25
Total Debt/Equity
0.13
0.68
0.90
0.85
0.80
0.77
0.70
0.63
0.72
0.74
Interest Cover
4.73
0.40
-0.17
0.23
0.41
1.09
1.06
3.35
3.55
2.85

News Update:


  • Venus Remedies gets CII’s Responsible Export Organisation Certification
    13th Apr 2022, 18:00 PM

    The company is poised to set industry standards which enhance the competitiveness of Indian exports

    Read More
  • Venus Remedies wins WHO GDP certification for quality services across entire supply chain
    9th Mar 2022, 12:59 PM

    The company has consistently maintained impeccable standards in its distribution operations and processes through proven quality management systems

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.